Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 -2.93K%
March 31, 2026 -2.10K%
December 31, 2025 -3.50K%
September 30, 2025 -25.10%
June 30, 2025 -2.03K%
March 31, 2025 -686.3%
December 31, 2024 -72.49%
September 30, 2024 -30.70%
June 30, 2024 -23.31%
March 31, 2024 -6.39%
December 31, 2023 -11.20%
September 30, 2023 -21.33%
June 30, 2023 -7.99%
March 31, 2023 -40.24%
December 31, 2022 -58.81%
September 30, 2022 -16.46%
June 30, 2022 -24.22%
March 31, 2022 -14.81%
December 31, 2021 -45.76%
September 30, 2021 -35.64%
June 30, 2021 -51.61%
March 31, 2021 -23.81%
December 31, 2020 -31.16%
September 30, 2020 -56.49%
June 30, 2020 -18.15%
Date Value
March 31, 2020 47.20%
December 31, 2019 16.34%
September 30, 2019 48.31%
June 30, 2019 27.14%
March 31, 2019 8.09%
December 31, 2018 22.72%
September 30, 2018 28.72%
June 30, 2018 25.09%
March 31, 2018 -18.54%
December 31, 2017 13.98%
September 30, 2017 16.97%
June 30, 2017 1.95%
March 31, 2017 -27.16%
December 31, 2016 18.03%
September 30, 2016 19.79%
June 30, 2016 2.66%
March 31, 2016 -22.85%
December 31, 2015 -22.69%
September 30, 2015 -33.05%
June 30, 2015 -66.88%
March 31, 2015 -10.40%
December 31, 2014 23.40%
September 30, 2014 -28.16%
June 30, 2014 -42.80%
March 31, 2014 -20.71%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Swedencare AB 3.54%
Camurus AB 34.30%
Moberg Pharma AB -56.91%
Infant Bacterial Therapeutics AB --
AstraZeneca PLC 20.15%